clavulanic acid has been researched along with Burkholderia pseudomallei Infection in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Do, CD; Doan, PM; Göhler, A; Hoang, SN; Hoang, TS; Krumkamp, R; May, J; Nguyen, LTN; Nguyen, TT; Que, TA; Steinmetz, I; Tran, DA; Trinh, TT; Trinh, VT | 1 |
| Dance, D | 1 |
| Khosravi, Y; Mariappan, V; Ng, SL; Vadivelu, J; Vellasamy, KM | 1 |
| Baker, P; Moore, RA; Tribuddharat, C; Woods, DE | 1 |
| Chaowagul, W; Chierakul, W; Dance, DA; Day, NP; Lindegardh, N; Maharjan, B; Peacock, SJ; Pongtavornpinyo, W; Short, JM; Singtoroj, T; Teparrukkul, P; Wangboonskul, J; White, NJ; Wuthiekanun, V | 1 |
| Jasper, LC; Liu, Y; Ooi, EE; Sim, SH; Sivalingam, SP; Wang, D | 1 |
| Perret, JL; Thibault, F; Vidal, D | 1 |
2 review(s) available for clavulanic acid and Burkholderia pseudomallei Infection
| Article | Year |
|---|---|
Treatment and prophylaxis of melioidosis.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Burkholderia pseudomallei; Carbapenems; Ceftazidime; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Infusions, Parenteral; Melioidosis; Sulfamethoxazole; Trimethoprim | 2014 |
[Pulmonary melioidosis].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Chloramphenicol; Clavulanic Acid; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Humans; Melioidosis; Penicillins; Pneumonia, Bacterial; Radiography, Thoracic; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
5 other study(ies) available for clavulanic acid and Burkholderia pseudomallei Infection
| Article | Year |
|---|---|
A simple laboratory algorithm for diagnosis of melioidosis in resource-constrained areas: a study from north-central Vietnam.
Topics: Algorithms; Amoxicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; Blood Culture; Burkholderia pseudomallei; Clavulanic Acid; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Melioidosis; Rec A Recombinases; Vietnam | 2018 |
Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Burkholderia pseudomallei; Clavulanic Acid; DNA Fingerprinting; Drug Resistance, Bacterial; Gene Expression; Humans; Imipenem; Malaysia; Melioidosis; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition.
Topics: 3' Flanking Region; 5' Flanking Region; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Burkholderia pseudomallei; Ceftazidime; Clavulanic Acid; Humans; Melioidosis; Microbial Sensitivity Tests; Molecular Sequence Data; Phenotype; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
Pharmacokinetic and pharmacodynamic assessment of co-amoxiclav in the treatment of melioidosis.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acid; Humans; Melioidosis; Middle Aged; Time Factors | 2006 |
Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole.
Topics: Amoxicillin; Animals; Antibiotic Prophylaxis; Burkholderia pseudomallei; Clavulanic Acid; Doxycycline; Drug Therapy, Combination; Female; Melioidosis; Mice; Mice, Inbred BALB C; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |